The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli
详细信息 查看全文
- 作者：Fusun Cana ; Ö ; zlem Kurt-Azapb ; Pelin İspira ; Elif Nurtopa ; Ceren Serefa ; İlayda Loç ; larc ; Ozge Nur Aktaşc ; Yelda Ceren Orhanc ; Onder Ergonuld ; oergonul@ku.edu.tr" class="auth_mail" title="E-mail the corresponding author
- 关键词：Urinary tract infection ; Multidrug-resistant ; Escherichia coli ; ST131 ; H30-Rx
- 刊名：Journal of Global Antimicrobial Resistance
- 出版年：2016
- 出版时间：March 2016
- 年：2016
- 卷：4
- 期：Complete
- 页码：49-52
- 全文大小：491 K
文摘
- •
Approximately 20% of multidrug-resistant (MDR) isolates were H30-Rx subclone.
- •
Urinary MDR Escherichia coli ST131 H30-Rx subclone was found to be important in dissemination of MDR UTIs in the community.
- •
Infection with this subclone was found to be healthcare-associated.